Joined
·
625 Posts
You need side effects and mechanisms more than the latest drugs in the class... remember many doctors are still using older drugs they know well rather than new shiny ones
That being said - know the new classes that have new mechanisms like, for example:
a) streptogramins and
b) Incretin based therapies (GLP-1 mimetics - exenatide and DPP4 antagonists - gliptins) for diabetes.
These types of drugs are not only fair game -they are a good USMLE target. Plus, they are HUGE news in current clinical use.
That being said - know the new classes that have new mechanisms like, for example:
a) streptogramins and
b) Incretin based therapies (GLP-1 mimetics - exenatide and DPP4 antagonists - gliptins) for diabetes.
These types of drugs are not only fair game -they are a good USMLE target. Plus, they are HUGE news in current clinical use.